NCT00412243: Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients |
|
|
| Completed | 1/2 | 51 | US | Clofarabine, Clorarex, Clolar, Cyclophosphamide, Cytoxan, Neosar | M.D. Anderson Cancer Center, Genzyme, a Sanofi Company | Burkitt's Lymphoma, Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia | 04/12 | 04/12 | | |
